US Retinal Biologics Market Segmentation
US Retinal Biologics Market By Drug Class (USD Million, 2025-2035)
- TNF-a inhibitor
- VEGF-A antagonist
US Retinal Biologics Market By Indication (USD Million, 2025-2035)
- macular degeneration
- diabetic retinopathy
- uveitis
- others
US Retinal Biologics Market By Distribution Channel (USD Million, 2025-2035)
- hospitals and clinics
- pharmacies
- others